In this episode of ATTD 2025 Conference Catch-Up, we dive into CGM as a Potential Diagnostic Tool, featuring insights on the evolving role of Continuous Glucose Monitoring (CGM) in diagnosing and managing both Type 1 and Type 2 diabetes, with a focus on early detection and precision medicine. Join us as we summarize key takeaways from these thought-provoking presentations: Precision Medicine in Stage 2 Type 1 Diabetes – Prof. Chantal Mathieu Data-Driven Approaches in Endocrinology: From CGM to Omics Data – Dr. Smadar Shilo Consensus on the Use of CGM in Individuals with Type 2 Diabetes – Prof. Tadej Battelino This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to stay on top of the latest advancements in CGM technologies and their role in early diabetes diagnosis and management. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related